The
global Hematology
Diagnostics Market size is expected to reach USD 9.39 billion by 2025,
according to a new report by Grand View Research, Inc. It is anticipated to
register a CAGR of 5.85% over the forecast period. Increasing prevalence of
blood disorders coupled with adoption of automated testing processes are
projected to propel the market growth.
Automation
of hematology diagnostics process have led to reduced turnaround time thereby
accelerating the overall treatment regimen. Furthermore, automation has also
led to reduced administrative errors and overall costs of diagnostic tests.
Thus, it is expected to boost growth of the hematology testing market in the
forthcoming years.
Dominance
of hematology analyzers can be attributed to the presence of fully-automated
analyzers which are objective, have high-throughput, and are cost-effective.
Furthermore, these hematology analyzers can also detect atypical results and
can improve measurable parameters such as red cell distribution width, platelet
distribution, Reticulocyte (RET) counts, and nucleated red cells counts.
The
advent of Point-Of-Care (PoC) hematology testing devices has led to improved
diagnostic and patient outcomes. These devices are user-friendly and are
available for use outside the hospital settings. This is anticipated to
increase the acceptability and accessibility of hematology testing which, in
turn, is anticipated to propel market growth.
Product
recall and intense market competition leading to price wars are anticipated to
hinder market growth. In 2018, Becton Dickinson (BD) and Company recalled
Vacutainer EDTA Blood Collection Tubes owing to chemical interference with
certain tests. This recall was classified as Class I recall, the most serious
type of recall, by the Food and Drug Administration (FDA), thereby indicating
that the use of these devices may cause serious injuries or death. Such product
recalls can negatively affect the market growth.
Related Press
Release@ Hematology
Diagnostics Market Report
Hematology Diagnostics Market Report Highlights
- Consumables
emerged as the largest segment owing to increasing testing and diagnosis
of blood disorders
- Diagnostic
labs segment is projected to expand at a lucrative CAGR over the forecast
period owing to high prevalence of blood disorders
- North
America held the dominant market share in 2017 owing to favorable
reimbursement scenario and presence of sophisticated technological
facilities
- Asia Pacific
is projected to witness swift growth during the forecast period owing to
the rising healthcare expenditure coupled with focus on quality healthcare
infrastructure
- Few of the
key players in hematology testing market include Beckman Coulter, Inc.;Abbott Laboratories; F. Hoffmann-La Roche
Ltd.; Siemens Healthineers; Mindray Medical International Limited; and
Sysmex Corporation.
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment